High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine–pyrimethamine

MLA

Zakeri, Sedigheh, et al. “High Prevalence of the 437G Mutation Associated with Sulfadoxine Resistance among Plasmodium Falciparum Clinical Isolates from Iran, Three Years after the Introduction of Sulfadoxine–pyrimethamine.” International Journal of Infectious Diseases, vol. 14, Sept. 2010, pp. e123–28. EBSCOhost, https://doi.org/10.1016/j.ijid.2009.11.035.

APA

Zakeri, S., Farahani, M. S., Afsharpad, M., Salehi, M., Raeisi, A., & Djadid, N. D. (2010). High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine–pyrimethamine. International Journal of Infectious Diseases, 14, e123–e128. https://doi.org/10.1016/j.ijid.2009.11.035

Chicago

Zakeri, Sedigheh, Maryam Shahrabi Farahani, Mandana Afsharpad, Masoud Salehi, Ahmad Raeisi, and Navid Dinparast Djadid. 2010. “High Prevalence of the 437G Mutation Associated with Sulfadoxine Resistance among Plasmodium Falciparum Clinical Isolates from Iran, Three Years after the Introduction of Sulfadoxine–pyrimethamine.” International Journal of Infectious Diseases 14 (September): e123–28. doi:10.1016/j.ijid.2009.11.035.